Worldwide Pharmaceutical Analytical Testing Industry to 2026 - Increasing Number of Clinical Trials is Driving Growth -

·3 min read

DUBLIN, October 25, 2021--(BUSINESS WIRE)--The "Pharmaceutical Analytical Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to's offering.

The pharmaceutical analytical testing market is expected to register a CAGR of 6.5% over the forecast period.

Companies Mentioned

  • Laboratory Testing Inc.

  • Eurofins Scientific

  • SGS SA

  • Toxikon Inc.

  • Pace Analytical Services

  • Intertek Phamaceutical Services

  • Boston Analytical

  • West Pharmaceutical Services Inc.

  • Steris

Key Market Trends

Stability Testing Segment is Expected to Exhibit a Significant Market Growth Over the Forecast Period

Statbility testing is done to evaluate the capability of the drug to retain it's properties throughout it's shelf-life. The stability testing is done on the basis of five parameters : Chemical, physical, microbiological, therapeutic and toxicity. The degredation with respect to any of these parameters can lead to health hazards.

According to the study published by Journal of Industrial Microbiology & Biotechnology, almost 300 biopharmaceuticals have been patented in the last three decaded. Furthermore, according to the World Health Organization, in 2019, the number of registered trials were around 92% in South East Asia and around 66% in the Eastern Mediterranean region. Hence, these factors are expected to impact positively on the market growth in this segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Pharmaceutical Analytical Testing market owing to increasing number of R&D activities and investments on it. According to the clinical, in 2019, around 293,321 studies were registered during the start of the year and around 32,523 at the end of year.

Furthermore, in 2019, approximately 48 novel drugs were approved as per the data of the FDA's Center for Drug Evaluation and Research (CDER). According to the Pharmaceutical Research & Manufacturers of America, in 2018, the R&D expenditure by biopharmaceutical companies were around 79.6 billion USD in the United States. Thus, the increasing number of clinical trials and number of approved drugs is expected to boost up the demand of pharmaceutical analytical testing market growth in the North America Region.

Key Topics Covered:





4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Number of Clinical Trials

4.2.2 Focus on Analytical Testing of Biologics & Biosimilars

4.2.3 Increased Trend of Outsourcing Laboratory Testing Services

4.3 Market Restraints

4.3.1 Complex Regulatory Framework for Maintaining Laboratories

4.3.2 Challenges in the Development of Proper Analytical Techniques

4.4 Porter's Five Force Analysis


5.1 By Service Type

5.2 Geography


6.1 Company Profiles


For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting